Alnylam to Webcast Conference Call Discussing Second Quarter 2025 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 223.63 -3.65 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $227.28 | 52 Week High | $109.10 | |||
| Open | $227.28 | 52 Week Low | $31.38 | |||
| Day High | $227.28 | P/E | N/A | |||
| Day Low | $222.00 | EPS | $-1.45 | |||
| Volume | 41,615 | |||||
